Merck KGaA
Other OTCTotal Valuation
Merck KGaA carries a market capitalization of 64.86B, placing it among publicly traded companies globally. Its enterprise value stands at 54.41B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 64.86B |
| Enterprise Value | 54.41B |
Share Statistics
Merck KGaA currently has 434.78M shares outstanding.
| Shares Outstanding | 434.78M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Merck KGaA trades at a trailing price-to-earnings ratio of 18.20. The price-to-sales ratio is 2.20, and the price-to-book ratio stands at 1.82.
| PE Ratio | 18.20 |
| PS Ratio | 2.20 |
| PB Ratio | 1.82 |
| P/TBV Ratio | 12.21 |
| P/FCF Ratio | 7.46 |
| P/OCF Ratio | 10.99 |
Enterprise Valuation
On an enterprise value basis, Merck KGaA trades at an EV/EBITDA multiple of 15.14 and an EV/FCF ratio of 8.37. The EV/Sales ratio of 2.60 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 15.14 provides insight into valuation relative to core operating earnings.
| EV / Sales | 2.60 |
| EV / EBITDA | 15.14 |
| EV / EBIT | 15.14 |
| EV / FCF | 8.37 |
Financial Position
Merck KGaA maintains a current ratio of 1.51, meaning it holds 1.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 40.37, indicating elevated leverage, while an interest coverage ratio of 8.72 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 1.51 |
| Quick Ratio | 0.40 |
| Debt / Equity | 40.37 |
| Debt / EBITDA | 3.35 |
| Interest Coverage | 8.72 |
Financial Efficiency
Merck KGaA posts a return on equity of 10.38 and a return on invested capital of 6.79.
| Return on Equity (ROE) | 10.38 |
| Return on Assets (ROA) | 4.94 |
| Return on Invested Capital (ROIC) | 6.79 |
| Return on Capital Employed (ROCE) | 8.16 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.87 |
Taxes
Over the trailing twelve months, Merck KGaA has paid 676.00M in income taxes, reflecting an effective tax rate of 20.99.
| Income Tax | 676.00M |
| Effective Tax Rate | 20.99 |
Stock Price Statistics
Merck KGaA's stock has gained approximately 9.65454% over the past 52 weeks. The 50-day moving average sits at 136.39, while the 200-day moving average is 137.94.
| Beta (5Y) | N/A |
| 52-Week Price Change | 9.65454% |
| 50-Day Moving Average | 136.39 |
| 200-Day Moving Average | 137.94 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Merck KGaA generated 20.96B in revenue and converted that into 2.53B in net income, yielding earnings per share of 5.86. EBITDA reached 3.59B, while operating income came in at 3.59B.
| Revenue | 20.96B |
| Gross Profit | 12.27B |
| Operating Income | 3.59B |
| Pretax Income | 3.22B |
| Net Income | 2.53B |
| EBITDA | 3.59B |
| EBIT | 3.59B |
| Earnings Per Share (EPS) | 5.86 |
Balance Sheet
Merck KGaA holds 3.77B in cash and equivalents against 12.04B in total debt, resulting in a net debt position of -2.74B. Total book value stands at 25.26B, with working capital of 4.81B providing operational flexibility.
| Cash & Cash Equivalents | 3.77B |
| Total Debt | 12.04B |
| Net Debt | -2.74B |
| Equity (Book Value) | 25.26B |
| Book Value Per Share | 58.11 |
| Working Capital | 4.81B |
Cash Flow
Merck KGaA produced 4.19B in operating cash flow over the past twelve months. After subtracting -1.98B in capital expenditures, free cash flow totaled 2.22B - equivalent to 5.10 per share.
| Operating Cash Flow | 4.19B |
| Capital Expenditures | -1.98B |
| Free Cash Flow | 2.22B |
| FCF Per Share | 5.10 |
Margins
Merck KGaA operates with a gross margin of 58.53, reflecting its pricing power and cost economics. The operating margin of 17.15 and net profit margin of 12.08 provide insight into operational efficiency.
| Gross Margin | 58.53 |
| Operating Margin | 17.15 |
| Pretax Margin | 15.37 |
| Profit Margin | 12.08 |
| EBITDA Margin | 17.15 |
Dividends & Yields
The company's payout ratio of 11.65 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.69 |
| Dividend Yield | N/A |
| Payout Ratio | 11.65 |
| Shareholder Yield | -4.72 |
| FCF Yield | 13.40 |
Stock Splits
Merck KGaA's most recent stock split took place on June 30, 2014 with a 1:2 split ratio.
| Last Split Date | 6/30/2014 |
| Split Ratio | 1:2 |
Scores
Merck KGaA posts an Altman Z-Score of 3.90, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 3.90 |